Asthma Inhaler Device Companies

Disclaimer: List of key companies in no particular orderLatest Asthma inhalers Companies Update

• 
  Sep 2023: Torrent Pharma is reportedly trying to raise the money required to acquire the Cipla promoter family. Torrent has approached several private equity (PE) groups regarding a minority investment in the business, including Advent Worldwide, Bain Capital, Warburg Pincus, and CVC Capital. With an equity investment of almost Rs 8,000 crore ($1 billion), this could be the nation's biggest acquisition in the pharmaceutical industry to date. Furthermore, the Ahmedabad-based Torrent is negotiating share-backed promoter financing worth roughly Rs 9,000–10,000 crore ($1.1 billion) with domestic shadow banks and mutual funds. Regarding operations, chronic and sub-chronic segments account for over 70% of revenue for both Torrent and Cipla. Cipla has historically concentrated on the respiratory, anti-infectives, and urology segments, whereas Torrent possesses strengths in the therapeutic areas of cardiac, diabetes, neuro/CNS, and gastro. According to industry experts, their combined portfolio may consist of 33 mega brands—each with a turnover above Rs 100 crore—and leading positions in 270 brands within their respective therapeutic areas.

• 
  Aug 2023: German pharmaceutical manufacturer Boehringer Ingelheim sold its Ondero and Ondero Met brands to multinational pharmaceutical giant Lupin Ltd. The business notified the stock exchanges that it had successfully acquired the brands following a deed of assignments it had signed with Boehringer Ingelheim International GmbH, Germany, last year. The purchase of trademark rights for the diabetic products Ondero and Ondero Met is also included in this. As part of a comarketing partnership with Boehringer Ingelheim India, the multinational pharmaceutical firm located in Mumbai has been selling both brands in the Indian market since 2015.

• GlaxoSmithKline plc (UK)


• Koninklijke Philips NV (Netherlands)


• AstraZeneca (UK)


• Cipla Inc. (India)


• Boehringer Ingelheim International GmbH (Germany)


• Beximco Pharmaceuticals Ltd (Bangladesh)


• Merck & Co., Inc. (the US)


• Teva Pharmaceutical Industries Ltd (Israel)


• Chiesi Farmaceutici SpA (Italy)


• and Medisol Lifescience Pvt. Ltd (India)